Patent Assignment
Reel/Frame 020721/0965
Assignment of Assignor's Interest
Recorded: 2008-03-28
Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2007-12-19
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Rnai Modulation of Scap and Therapeutic Uses Thereof
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 7, 2007
From: HORTON, JAY D.; BROWN, MICHAEL S.; GOLDSTEIN, JOSEPH L.; MOON, YOUNG-AH
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020212/0221 →
Assignment of Assignor's Interest
Mar 28, 2008
From: HORTON, JAY D.; BROWN, MICHAEL S.; GOLDSTEIN, JOSEPH L.; MOON, YOUNG-AH
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020721/0930 →
Assignment of Assignor's Interest
Mar 28, 2008
From: SOUTSCHEK, JUERGEN; TAN, PAMELA
To: ALNYLAM EUROPE AG
Reel/Frame 020721/0953 →
Confirmatory License
Oct 19, 2008
From: UNIVERSITY OF TEXAS SW MEDICAL CENTER AT DALLAS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021700/0155 →